192IgG-Saporin immunotoxin and ibotenic acid lesions of nucleus basalis and medial septum produce comparable deficits on delayed nonmatching to position in rats

Psychobiology

Volumn 24, Issue 3, 1996, Pages 179-186

  Robinson, John K ^a,e   Wenk, Gary L ^b   Wiley, Ronald G ^c   Lappi, Douglas A ^d   Crawley, Jacqueline N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Advanced Targeting Systems   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBOTENIC ACID; IMMUNOGLOBULIN G; IMMUNOTOXIN; SCOPOLAMINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; IMMUNOTOXICITY; MALE; NEUROMODULATION; NONHUMAN; OLIVARY NUCLEUS; RAT; TASK PERFORMANCE; WORKING MEMORY;

EID: 0029845763     PISSN: 08896313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 192IgG-Saporin lesions of basal forebrain cholinergic cells: Effects on learning and memory in rats. Society for Neuroscience Abstracts, 20, 1215.
2. BERGER-SWEENEY, J., HECKERS, S. M., MESULAM, M.-M., WILEY, R. G., LAPPI, D. A., & SHARMA, M. (1994). Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of medial septal area and nucleus basalis magnocellularis. Journal of Neuroscience, 14, 4507-4519.
3. BOWEN, D. M., SMITH, C. B., WHITE, P., & DAWSON, A. N. (1976). Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other atrophies. Brain, 99, 459.
4. BUSHNELL, P. J. (1990). Modelling working and reference memory in rats: Effects of scopolamine on delayed matching-to-position. Behavioral Pharmacology, 1, 419-427.
5. COYLE, J. T., PRICE, D. L., & DELONG, M. R. (1982). Alzheimers disease: A disorder of cortical cholinergic innervation. Science, 19, 1184-1190.
6. DAVIES, P., & MALONEY, A. J. F. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2, 1403.
7. DUNNETT, S. B. (1985). Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology, 87, 357-363.
8. DUNNETT, S. B., EVERITT, B. J., & ROBBINS, T. W. (1991). The basal-forebrain cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends in Neurosciences, 14, 494-501.
9. DUNNETT, S. B, ROGERS, D. C., & JONES, G. H. (1989). Effects of nucleus basalis magnocellularis lesions in rats on delayed matching and non-matching to position tasks. European Journal of Neuroscience, 1, 395-406.
10. FONNUM, F. (1969). Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochemistry Journal, 115, 465-472.
11. HAGAN, J. J., & MORRIS, R. G. M. (1988). The cholinergic hypothesis of memory: a review of animal experiments. In L. L. Iversen, S. D. Iversen, & S. H. Snyder (Eds.), Handbook of psychopharmacology: Psychopharmacology of the aging nervous system (Vol. 20, pp. 217-323). New York: Plenum.
12. HARRINGTON, C. A., MOBLEY, S. L., & WENK, G. L. (1994). Nitric oxide formation does not underlie the memory deficits produced by ibotenate injections into the nucleus basalis of rats. Behavioral Neuroscience, 108, 277-283.
13. HECKERS, S., OHTAKE, T., WILEY, R. G., LAPPI, D. A., GEULA, C., & MESULAM, M. (1994). Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. Journal of Neuroscience, 14, 1271-1289.
14. KELLY, R. M., WALSH, T. J., OPELLO, K. D., STACKMAN, R. W., KUTSCHER, C. L., & WILEY, R. G. (1994). Destruction of the cholinergic basal forebrain by 192-saporin: Behavioral and neurobiological correlates. Society for Neuroscience Abstracts, 20, 150.
15. LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L., & RANDALL, R. J. (1951). Protein measurement with folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
16. MASTROPAOLO, J., NADI, N., OSTROWSKI, N. L., & CRAWLEY, J. N. (1988). Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proceedings of the National Academy of Sciences, 85, 9841-9845.
17. MOLCHAN, S. E., MARTINEZ, R. A., HILL, J. A., WEINGARTNER, H. J., THOMPSON, K., VITIELLO, B., & SUNDERLAND, T. (1992). Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Research Reviews, 17, 215-226.
18. NILSSON, O. G., LEANZA, G., ROSENBLAD, C., LAPPI, D. A., WILEY, R. G., & BJORKLUND, A. (1992). Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. Neuroreport, 3, 1005-1008.
19. OLTON, D. S., & WENK, G. L. (1987). Dementia: Animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 941-953.). New York: Raven Press.
20. PAXINOS, G., & WATSON, C. (1986). The rat brain in stereotaxic coordinates (2nd ed.). San Diego, CA: Academic Press.
21. ROBINSON, J. K., & CRAWLEY, J. N. (1993a). Intraseptal galanin potentiates scopolamine disruption of delayed nonmatching-to-sample. Journal of Neuroscience, 13, 5119-5125.
22. ROBINSON, J. K., & CRAWLEY, J. N. (1993b). Intraventricular galanin disrupts delayed nonmatching-to-sample in rats. Behavioral Neuroscience, 107, 458-467.
23. ROBINSON, J. K., & CRAWLEY, J. N. (1994). Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats. Behavioral Neuroscience, 108, 941-950.
24. SAKURAI, Y., & WENK, G. L. (1990). The interaction of acetylcholinergic and serotonergic neural systems on performance in a continuous non-matching to sample task. Brain Research, 519, 118-121.
25. TORRES, E. M., PERRY, A., BLOKLAND, A., WILKINSON, L. S., WILEY, R. G., LAPPI, D. A., & DUNNETT, S. B. (1994). Behavioral, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience, 63, 95-122.
26. WAITE, J. J., CHEN, A. D., WARDLOW, M. L., WILEY, R. G., LAPPI, D. L., & THAL, L. J. (1995). 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and Purkinje cells. Neuroscience, 65, 463-476.
27. WENK, G. L., & OLTON, D. S. (1987). Basal forebrain cholinergic neurons and Alzheimer's disease. In J. T. Coyle (Ed.), Animal models of dementia (pp. 81-101). New York: Alan R. Liss.
28. WENK, G. L., STOEHR, J. D., QUINTANA, G., MOBLEY, S., & WILEY, R. G. (1994). Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. Journal of Neuroscience, 14, 5986-5995.
29. WILEY, R. G. (1992). Neural lesioning with ribosome-inactivating proteins: Suicide transport and immunolesioning. Trends in Neurosciences, 15, 285-290.
30. WILEY, R. G., BERBOS, T. J., DECKWITH, T., JOHNSON, E. M., JR., & LAPPI, D. A. (1995). Destruction of the cholinergic basal forebrain using immunotoxin to the rat NGF receptor: Modeling the cholinergic degeneration of Alzheimer's disease. Journal of Neurological Sciences, 128, 157-166.
31. WILEY, R. G., & LAPPI, D. A. (1993). Preparation of anti-neuronal immunotoxins for selective immunolesioning. Neuroscience Protocols, 93-020, 1-11.
32. WILEY, R. G., & LAPPI, D. A. (1994). Suicide transport and immunolesioning. Austin, TX: R. G. Landes Biomedical Publishers.